Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
06 2019
Historique:
received: 05 11 2018
accepted: 20 03 2019
pubmed: 30 3 2019
medline: 19 5 2020
entrez: 30 3 2019
Statut: ppublish

Résumé

Platelet autoantibody-induced platelet clearance represents a major pathomechanism in immune thrombocytopenia (ITP). There is growing evidence for clinical differences between anti-glycoprotein IIb/IIIa and anti-glycoprotein Ib/IX mediated ITP. Glycoprotein V is a well characterized target antigen in Varicella-associated and drug-induced thrombocytopenia. We conducted a systematic study assessing the prevalence and functional capacity of autoantibodies against glycoprotein V. A total of 1140 patients were included. In one-third of patients, platelet-bound autoantibodies against glycoproteins Ib/IX, IIb/IIIa, or V were detected in a monoclonal antibody immobilization of platelet antigen assay; platelet-bound autoantiglycoprotein V was present in the majority of samples (222 out of 343, 64.7%). Investigation of patient sera revealed the presence of free autoantibodies against glycoprotein V in 13.5% of these patients by an indirect monoclonal antibody immobilization of platelet antigen assay, but in 39.6% by surface plasmon resonance technology. These antibodies showed significantly lower avidity (association/dissociation ratio 0.32±0.13

Identifiants

pubmed: 30923095
pii: haematol.2018.211086
doi: 10.3324/haematol.2018.211086
pmc: PMC6545841
doi:

Substances chimiques

Autoantibodies 0
Autoantigens 0
Platelet Membrane Glycoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1237-1243

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright© 2019 Ferrata Storti Foundation.

Références

J Thromb Haemost. 2014 Apr;12(4):497-504
pubmed: 24517219
Br J Haematol. 2003 Sep;122(5):818-24
pubmed: 12930395
Blood. 2002 Jul 1;100(1):344-6
pubmed: 12070047
PLoS One. 2016 Aug 05;11(8):e0160563
pubmed: 27494140
Br J Haematol. 1997 Jan;96(1):204-9
pubmed: 9012711
Blood. 1982 Jan;59(1):23-6
pubmed: 7032627
Transfus Sci. 1998 Sep;19(3):237-44
pubmed: 10351135
Blood. 2018 Feb 15;131(7):787-796
pubmed: 29203584
J Biol Chem. 1992 Jan 5;267(1):364-9
pubmed: 1730602
Br J Haematol. 2009 Sep;146(6):585-96
pubmed: 19466980
Pediatr Res. 1996 Oct;40(4):615-9
pubmed: 8888292
Transfusion. 2011 Nov;51(11):2455-61
pubmed: 21564107
Semin Hematol. 2007 Oct;44(4 Suppl 5):S3-S11
pubmed: 18096470
Br J Haematol. 2003 Feb;120(4):574-96
pubmed: 12588344
Br J Haematol. 1997 Aug;98(2):328-35
pubmed: 9266929
Ann Hematol. 1996 Apr;72(4):280-5
pubmed: 8624385
Thromb Haemost. 2013 Dec;110(6):1259-66
pubmed: 24067937
Clin Chim Acta. 2016 Jul 1;458:72-7
pubmed: 27129630
Blood. 2001 Jul 15;98(2):368-73
pubmed: 11435305
Br J Haematol. 1991 Oct;79(2):256-62
pubmed: 1720324
J Lab Clin Med. 1951 Jul;38(1):1-10
pubmed: 14850832
Blood. 2010 Jan 14;115(2):168-86
pubmed: 19846889
Autoimmun Rev. 2016 Aug;15(8):843-7
pubmed: 27296447
Br J Haematol. 2018 Aug;182(3):423-426
pubmed: 29808904
Blood. 1994 Feb 15;83(4):1024-32
pubmed: 8111044
Ann N Y Acad Sci. 1981;370:87-95
pubmed: 6943980
Nat Commun. 2015 Jul 17;6:7737
pubmed: 26185093
J Biol Chem. 2005 Apr 15;280(15):14462-8
pubmed: 15691827
Blood. 2015 Mar 12;125(11):1793-802
pubmed: 25548320
Blood. 1986 May;67(5):1377-81
pubmed: 2938647
Blood. 2009 Jun 25;113(26):6511-21
pubmed: 19395674
Nat Med. 2003 Sep;9(9):1123-4
pubmed: 12937414
Eur J Haematol. 2012 Feb;88(2):167-74
pubmed: 21985182
Blood. 1987 Dec;70(6):1722-6
pubmed: 2445398
Am J Hematol. 2012 Feb;87(2):206-8
pubmed: 22139961
Thromb Haemost. 2015 Jan;113(1):107-17
pubmed: 25231551
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13336-41
pubmed: 10557321
Clin Lab Haematol. 2001 Oct;23(5):307-12
pubmed: 11703413

Auteurs

Richard Vollenberg (R)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

Rabie Jouni (R)

Center for Clinical Transfusion Medicine, Medical Faculty of Tübingen, Eberhard Karls University, Tübingen, Germany.

Peter A A Norris (PAA)

The Canadian Blood Services & The Keenan Research Centre of St. Michael's Hospital, Toronto, ON, Canada.

Monika Burg-Roderfeld (M)

Faculty for Chemistry and Biology, Fresenius University of Applied Sciences, Idstein, Germany.

Nina Cooper (N)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

Mathias J Rummel (MJ)

IVth Department of Internal Medicine (Hematology/Oncology), Justus Liebig University, Giessen, Germany.

Gregor Bein (G)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

Irene Marini (I)

Center for Clinical Transfusion Medicine, Medical Faculty of Tübingen, Eberhard Karls University, Tübingen, Germany.

Behnaz Bayat (B)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

Richard Burack (R)

Department of Pathology and Laboratory Medicine, University of Rochester, NY, USA.

Alan H Lazarus (AH)

The Canadian Blood Services & The Keenan Research Centre of St. Michael's Hospital, Toronto, ON, Canada.

Tamam Bakchoul (T)

Center for Clinical Transfusion Medicine, Medical Faculty of Tübingen, Eberhard Karls University, Tübingen, Germany.

Ulrich J Sachs (UJ)

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany ulrich.sachs@med.uni-giessen.de.
Center for Transfusion Medicine and Hemotherapy and Hemostasis Center, University Hospital Giessen and Marburg, Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH